Impact of selexipag maintenance dose on persistence, adherence, and hospitalization in US patients with pulmonary arterial hypertension

Documenti analoghi

• Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States
  di: Harrison W. Farber, et al.
  Pubblicazione: (2024)
• Impact of general anesthesia on the echocardiographic assessment of right ventricular function in pediatric patients with pulmonary arterial hypertension
  di: Charles T. Simpkin, et al.
  Pubblicazione: (2024)
• An adult patient with pulmonary arterial hypertension, a NOTCH3 mutation, and leflunomide exposure
  di: Elizabeth G. Fenner, et al.
  Pubblicazione: (2024)
• The effects of oxygenation on acute vasodilator challenge in pulmonary arterial hypertension
  di: Matthew D. Rockstrom, et al.
  Pubblicazione: (2024)
• Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
  di: Salaheldin Ahmed, et al.
  Pubblicazione: (2024)